Moderna Starts Phase 3 Trial For Its Coronavirus Vaccine; MRNA Stock Jumps

Moderna Starts Phase 3 Trial For Its Coronavirus Vaccine; MRNA Stock Jumps

Moderna is racing to develop a coronavirus vaccine in what could be record time, along with a bevy of rivals seeking to end the Covid-19 pandemic with a safe, effective preventive treatment.